BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen CH, Li SH. A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy. J Thorac Dis 2017;9:1446-9. [PMID: 28740654 DOI: 10.21037/jtd.2017.05.57] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Nariman-Saleh-Fam Z, Saadatian Z, Daraei A, Mansoori Y, Bastami M, Tavakkoli-Bazzaz J. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research. Biomark Med 2019;13:147-59. [PMID: 30672305 DOI: 10.2217/bmm-2018-0127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
2 Zhang Z, Ma M, Hu R, Xu B, Zong L, Wei H, Meng Y. RasGRP3, a Ras guanyl releasing protein 3 that contributes to malignant proliferation and aggressiveness in human esophageal squamous cell carcinoma. Clin Exp Pharmacol Physiol 2018;45:720-8. [PMID: 29461644 DOI: 10.1111/1440-1681.12926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]